This grant seeks to expand a cost-effective methodology for obtaining drug early warning indicators by re-testing existing urine samples from emergency department and trauma unit patients. The project will re-analyze discarded specimens, originally collected for other purposes, for an expanded panel of illicit drugs including fentanyl, xylazine, and new psychoactive substances. This aims to identify emerging drug trends, assess what conventional tests miss, and understand variations across populations and regions. By leveraging pre-collected samples, this approach offers a timely and inexpensive snapshot of drug patterns. The initiative will also integrate analysis of de-identified electronic health records to provide broader regional and national context. The ultimate goal is to reinforce best practices, standardize testing, and build robust local and national substance use surveillance capacity within hospital systems across the United States.
Opportunity ID: 356384
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | EDS-EDS-24-001 |
Funding Opportunity Title: | Emergency Department Substance Use Surveillance System |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 1 |
Assistance Listings: | 95.007 — Research and Data Analysis |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Sep 10, 2024 |
Last Updated Date: | Sep 10, 2024 |
Original Closing Date for Applications: | Sep 17, 2024 No Explanation |
Current Closing Date for Applications: | Sep 17, 2024 No Explanation |
Archive Date: | Oct 17, 2024 |
Estimated Total Program Funding: | – |
Award Ceiling: | $150,000 |
Award Floor: | $0 |
Eligibility
Eligible Applicants: | Private institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education |
Additional Information on Eligibility: | – |
Additional Information
Agency Name: | Office of National Drug Control Policy |
Description: | This project seeks to further refine and geographically expand a methodology for obtaining drug early warning indicators through broader testing of urine samples that were previously collected and tested as part of an existing drug test protocol. This method was initially developed using local criminal justice populations – including persons in pre-trial or lock-up, parolees or probationers, and drug court participants. A similar methodology is promising for use in other venues, such as in trauma units and emergency departments, where biological samples are often collected from patients. Before the specimens are discarded, the project will re-test them for an expanded panel of drugs, including xylazine, fentanyl, methamphetamine, and other new psychoactive substances (NPS); to determine what old and new illicit drugs are detected or missed by conventional testing protocols, and how the drug patterns might vary by subpopulation and geography. Bypassing the expense of collecting the original specimens and re-using those that have already been tested with known results yields a relatively inexpensive and timely picture of emerging drugs in a given subpopulation and locality. Hospital and de-identified nationally representative patient electronic health records (EHRs) should be collected and analyzed to put re-tested urine positivity results into a larger regional and national context of drug exposure and consequences. ONDCP is seeking to apply this testing methodology and insight from supplemental EHR investigations to emergency department and other hospital-system populations in locations throughout the United States to reinforce best practice guidelines, testing standardization, and build local and national surveillance capacity. |
Link to Additional Information: | Emergency Department Substance Use Surveillance System |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Grants.gov Contact Center
Phone Number: 1-800-518-4726 Hours of operation are 24 hours a day, 7 days a week. The contact center is closed on federal holidays. |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | Grants.gov Contact Center Phone Number: 1-800-518-4726 Hours of operation are 24 hours a day, 7 days a week. The contact center is closed on federal holidays. |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
PKG00287884 | Sep 10, 2024 | Sep 17, 2024 | View |
Package 1
Mandatory forms
356384 SF424_4_0-4.0.pdf
356384 SF424B-1.1.pdf
356384 SF424A-1.0.pdf
356384 BudgetNarrativeAttachments_1_2-1.2.pdf
356384 SFLLL_2_0-2.0.pdf
Optional forms
356384 SF424D-1.1.pdf
356384 AttachmentForm_1_2-1.2.pdf
356384 SF424C_2_0-2.0.pdf